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Abstract
The aetiology of endometriosis is still unclear and to find mechanisms behind the disease development, it is important to study each 
cell type from endometrium and ectopic lesions independently. The objective of this study was to uncover complete mRNA profiles in 
uncultured stromal cells from paired samples of endometriomas and eutopic endometrium. High-throughput mRNA sequencing 
revealed over 1300 dysregulated genes in stromal cells from ectopic lesions, including several novel genes in the context of 
endometriosis. Functional annotation analysis of differentially expressed genes highlighted pathways related to cell adhesion, 
extracellular matrix–receptor interaction and complement and coagulation cascade. Most importantly, we found a simultaneous 
upregulation of complement system components and inhibitors, indicating major imbalances in complement regulation in ectopic 
stromal cells. We also performed in vitro experiments to evaluate the effect of endometriosis patients’ peritoneal fluid (PF) on 
complement system gene expression levels, but no significant impact of PF on C3, CD55 and CFH levels was observed. In conclusion, 
the use of isolated stromal cells enables to determine gene expression levels without the background interference of other cell types. 
In the future, a new standard design studying all cell types from endometriotic lesions separately should be applied to reveal novel 
mechanisms behind endometriosis pathogenesis.
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Introduction
Endometrial tissue outside the uterine cavity can 
form lesions on ovaries and other peritoneal organs, 
resulting in endometriosis. As the molecular aetiology 
of endometriosis is still unclear, it is important to detect 
gene expression alterations in endometriotic lesions 
and eutopic endometrium of endometriosis patients. 
Three major types of endometriotic lesions are known, 
peritoneal lesions, ovarian endometriomas and deep 
infiltrating lesions (Nisolle & Donnez 1997), that are 
distinct clinical entities with unique histopathogeneses 
accompanied by specific expression profiles, depending 
on the anatomical location of lesions (Meola et al. 2010, 
Ballester  et  al. 2012, Filippi  et  al. 2016). Therefore, it 
seems reasonable to study endometriomas and lesions 
from other locations separately.
Several transcriptomic studies have been conducted 
to find molecular alterations in endometrial cells 
lining the inner surface of endometriomas (reviewed 
in Sanchez  et  al. 2015). However, despite hundreds 
to thousands of genes and specific pathways that have 
been revealed in these studies, the results remain 
inconclusive and no common molecular markers or 
pathways linked to endometriosis have been described. 
The most probable reason for these discordances could 
be the tissue heterogeneity of whole-lesion biopsies, 
as in addition to endometrial cells the endometrioma 
wall includes various proportions of ovarian stroma, 
follicles and fibrous tissue that prevent the detection 
of gene expression alterations characteristic to ectopic 
endometrial cells (reviewed in Sanchez et al. 2014). There 
are only a few studies utilizing pure cell populations for 
exploring gene expression in endometriotic lesions. The 
first study applied laser capture microdissection to gather 
epithelial cells from eu- and ectopic endometrial tissues 
(Wu et al. 2006), while another study analysed cultured 
immortalized stromal cells from ovarian endometriosis 
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(Kobayashi  et  al. 2012). The studies investigating gene 
expression alterations in purified and uncultured stromal 
cells from eu- and ectopic endometrial tissues are still 
missing, but could be a helpful source of information to 
understand the disease pathogenesis.
Therefore, the aim of the current study was to reveal 
the full transcriptome of uncultured endometrial stromal 
cells from paired samples of endometriomas and 
endometrium of the same woman.
Materials and methods
Patient characteristics and sample collection
The study protocol was approved by Research Ethics 
Committee of the University of Tartu (Tartu, Estonia). Patients 
were enrolled in the study from Tartu University Hospital’s 
Women’s Clinic after signing a written informed consent 
form. Endometriomas and eutopic endometrial tissue samples 
were obtained from 10 women to isolate stromal cells by 
fluorescence-activated cell sorting (FACS, Table 1). From nine 
patients (six with and three without endometriosis), eutopic 
endometrial samples were collected to establish primary 
cell cultures (Table  1). All tissue samples were collected 
during laparoscopy for suspected endometriosis or infertility. 
Endometrial samples were obtained using an endometrial 
suction catheter (Pipelle, Laboratoire CCD, Paris, France). 
Recruited women had not received hormonal medications at 
least three months before surgery. All collected tissue samples 
were immediately placed into the cryopreservation medium 
containing 1× Dulbecco’s Modified Eagle’s Medium (DMEM, 
Gibco, Thermo Fisher Scientific), 30% fetal bovine serum (FBS, 
Biowest, Riverside, MO, USA) and 7.5% Dimethyl Sulfoxide 
Hybri-Max (Sigma-Aldrich), placed into Nalgene Cryo 1°C ‘Mr 
Frosty’ Freezing Container (Thermo Scientific) and deposited 
into a −80°C freezer overnight. The frozen biopsies were stored 
in liquid nitrogen until further use. A proportion of the freshly 
collected endometrioma samples was placed into formalin for 
histopathological evaluation, and endometriosis diagnosis was 
verified on all endometrioma samples.
From a subset of patients (Table 1), peritoneal fluid (PF) was 
aspirated into a sterile 15 mL polystyrene tube and transported 
to the laboratory on ice within one hour. Blood-contaminated 
PFs were not collected. The PF was centrifuged (15 min, 
1200 g, at 4°C), filtered through a 0.22 µm pore size membrane 
(Millex GV filter, Merck Millipore) and stored at −80°C until 
further use.
Stromal cell isolation from eu- and ectopic endometria
Stromal cells were isolated from endometrial or endometrioma 
biopsies using FACS as described previously (Krjutskov et al. 
2016) with minor modifications for ectopic endometria. 
Briefly, endometrioma samples were rapidly thawed (<1 min) 
in a 37°C water bath, rinsed with medium, minced with sterile 
scalpel and then enzymatically digested with collagenase 
(Sigma-Aldrich) for up to 1 h. Erythrocytes were removed with 
ACK lysing buffer (Gibco, Thermo Fisher Scientific), and cell 
suspensions were filtered through 50 µm and 35 µm strainer 
(Cell Strainer Cap, BD Falcon, San Jose, CA, USA) to separate 
cells from undigested tissue fragments. Isolated cells from 
eu- and ectopic endometria were stained with phycoerythrin-
conjugated mouse anti-human CD10 antibody (1:20 dilution, 
clone HI10a, BD Pharmingen, USA) and prior to FACS, DAPI 
(1 mg/mL, 1:2000 dilution, Invitrogen) was added to the 
suspension to exclude dead cells from the analysis. On average, 
the viability of cells was 76.4% (ranging from 71.8 to 81.2%) 
and 76.4% (ranging from 72.4 to 83.2%) for endometrial and 
endometrioma biopsies, respectively. Alive CD10+ cells were 
sorted directly to QIAzol Lysis Reagent (Qiagen). Total RNA 
was isolated immediately using RNeasy Micro kit (Qiagen).
RNA sequencing
Before library construction, RNA was treated with DNA-free 
DNA Removal Kit (Invitrogen, Thermo Fisher Scientific), and 
the quality of the total RNA was analysed on Bioanalyzer 2100 
using RNA 6000 Nano chips (Agilent Technologies). Library 
construction and sequencing were performed at the Estonian 
Genome Center Core Facility (Tartu, Estonia). 100 bp paired-
end mRNA libraries were prepared using TruSeq Stranded 
mRNA Library Prep Kit (Illumina, San Diego, CA, USA) as 
per manufacturer’s instructions and were sequenced on 
Illumina HiSeq2500.
Table 1 General characteristics of the study participants.
Patient ID
Age 
(years)
BMI 
(kg/m2)
Menstrual 
cycle 
phasec
Endo-
metriosis 
stage Infertility
CD10+ stromal cell study
E213a,b 43 24.0 Proliferative III No
E218a,b 32 28.6 Proliferative III Yes, primary
E238a,b 32 20.0 Proliferative IV Yes, secondary
E244a,b 28 17.8 Proliferative III Yes, secondary
E160b 31 19.7 Proliferative IV No
E230b 35 17.6 Proliferative IV No
E270b 33 21.5 Proliferative III Yes, secondary
E302b 40 25.4 Proliferative III Yes, primary
E097b 25 17.9 Proliferative III Yes, primary
E224b 30 21.1 Proliferative II No
Cell culture study
E305* 30 29.1 Proliferative NA Yes, primary
E339* 32 21.8 Proliferative NA Yes, secondary
E324* 26 21.0 Proliferative NA Yes, primary
E279 22 21.4 Proliferative I Yes, primary
E316 28 19.0 Proliferative I No
E306 25 19.1 Proliferative I Yes, secondary
E142 31 20.1 Proliferative IV Yes, primary
E302 40 25.4 Proliferative III Yes, primary
E343 26 20.5 Proliferative I Yes, primary
Peritoneal fluid pool
E314 44 22.2 Secretory III No
E316 28 19.0 Proliferative I No
E327 35 20.2 Proliferative IV No
E330 35 24.5 Secretory III Yes, secondary
E331 30 23.4 Proliferative II No
E319 30 19.6 Secretory III Yes, primary
amRNA sequencing, bvalidation, cbased on the date of last 
menstruation reported by patient and *patients without 
endometriosis.
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Sequencing data analysis
Raw sequencing reads were quality controlled using FastQC 
version 0.9.5 (http://www.bioinformatics.bbsrc.ac.uk/projects/
fastqc/) and cutadapt version 1.8.1 (Martin 2011). Quality-
controlled reads were aligned to the human genome (NCBI 
build 37, hg19) using STAR (version 2.4.0j) alignment tool 
(Dobin et al. 2013). Gene and transcript level quantification 
of read counts was performed using HTSeq version 0.6.1 
(Anders  et  al. 2015). Differentially expressed genes (DEGs) 
between stromal cells from eutopic and ectopic endometria 
were identified using the edgeR (Robinson  et  al. 2010), 
DESeq2 (Love et al. 2014) and baySeq (v2) (Hardcastle 2016) 
packages. DEGs were defined as follows: (a) with adjusted 
P value ≤0.05, (b) with at least 2-fold difference between 
compared samples and (c) recognized by at least two out 
of three differential expression detection methods used. 
Biological mechanisms underlying DEGs were investigated 
using g:Profiler (Reimand et al. 2016).
Experiments with peritoneal fluid (PF)
Six PF samples collected from endometriosis patients (Table 1) 
were thawed, pooled together in equal amounts and the 
same PF pool was used in all experiments. Preconditioning 
experiments to optimize the supplemental PF concentration 
for endometrial cell cultures were performed with increasing 
amounts of PF pool (0, 10 or 25% of final concentration). As 
also previously demonstrated (Braza-Boils et al. 2015), 25% of 
final PF concentration was not toxic to cells (data not shown), 
and was used for further experiments.
Primary cultures of human endometrial stromal cells were 
prepared from frozen endometrial biopsies collected from 
nine patients (four with I–II stage endometriosis, two with III–IV 
stage endometriosis and three without endometriosis, Table 1). 
Single-cell suspensions of endometrial stromal cells for primary 
culture were isolated as described previously (Kasvandik et al. 
2016), isolated cells were seeded into the 24-well cell culture 
plate and cultured at 37°C in 5% CO2 until 90% of confluency 
was reached. Then medium was removed, and cells were 
washed twice with Mg2+- and Ca2+-free PBS. After washing, 
cells were treated either with medium containing PF (25% of 
final concentration) or without PF (0% of final concentration), 
supplemented with 100 pM oestradiol (Sigma-Aldrich) and 
incubated for 6, 12 and 24 at 37°C, 5% CO2 (Fig. 1A). After 
the exposure time, cells were washed twice with Mg2+- and 
Ca2+-free PBS, detached using 0.25% trypsin/0.02% EDTA 
(Gibco, Thermo Fisher Scientific) at 37°C, 15 min. For trypsin 
inactivation, the full media of DMEM/F12 with 10% FBS serum 
was added to the cell suspension and collected to low-binding 
tubes (Eppendorf, Hamburg, Germany). Cells were pelleted at 
300 g for 5 min at room temperature and lysed with QIAzol 
Lysis Reagent for subsequent RNA extraction. Total RNA was 
isolated using RNeasy Micro kit (Qiagen).
Real-time PCR
The relative expression of complement cascade genes (C3, 
CD55, CFH, A2M and SERPINA5), cell adhesion-related genes 
(SELP, ESAM, CLDN1 and CLDN11) and SERPINE2 was verified 
in uncultured stromal cells isolated by FACS from nine eutopic 
and 10 ectopic endometrial tissues (Table  1). Complement 
cascade genes C3, CD55 and CFH were also quantified from 
primary cultures of endometrial stromal cells conditioned 
with or without PF. cDNA was synthesized with RevertAid 
First Strand cDNA Synthesis Kit (Thermo Fisher Scientific), 
and real-time PCR was performed using 1× HOT FIREPol 
EvaGreen qPCR Mix Plus (ROX) (Solis BioDyne, Tartu, Estonia). 
Figure 1 (A) Experimental design of PF study; 
(B) average relative expression of complement 
cascade genes in PF experiments. The relative 
expression of C3, CD55 and CFH was 
measured from cells before cultivation 
(uncultured), after achieving confluency but 
before treatment with PF (0 h), and 6, 12 and 
24 h after adding PF. In parallel, untreated cells 
from the same biopsies were cultured and 
analysed at the same time points; PF, 
peritoneal fluid.
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SDHA  was used as a reference gene. Primer sequences are 
listed in Table 2. Fold change (FC) was calculated according to 
the 2−ΔΔCt method (Livak & Schmittgen 2001). Studied mRNA 
differences between eu- and ectopic endometrial stromal cells 
were analysed with two-tailed Student’s t-test, and P value 
≤0.05 was considered as significant. Relative expression levels 
in studied PF experiment groups at different time points were 
compared using ANOVA and Tukey–Kramer post hoc test.
Results
Gene expression profile of eu- and ectopic 
endometrial stromal cells
To identify DEGs between eutopic endometria and 
ovarian endometriomas, mRNA sequencing was 
performed on stromal cells isolated from four paired 
tissue samples. On average, 7.6 million reads (between 
7.0 and 8.6 million per sample) were obtained using 
Illumina HiSeq2500 platform of which 93% had high-
quality scores (≥Q30). Data analysis revealed 1395 
DEGs (FC ≥2, adjusted P values <0.05) from which 
339 and 1056 genes were more abundantly expressed 
in eutopic and ectopic endometrium, respectively 
(Supplementary Table 1, see section on supplementary 
data given at the end of this article). The top 15 most 
significantly down- and up-regulated genes are listed 
in Table 3.
Functional annotation analysis of all DEGs utilizing 
g:Profiler software revealed ‘Cell adhesion molecules’ 
(26 genes, P value 8.2E-08), ‘ECM-receptor interaction’ 
(17 genes, P value 3.0E-05) and ‘Complement and 
coagulation cascades’ (16 genes, P value 5.6E-04) as the 
most enriched KEGG pathways (Supplementary Table 2). 
Among other cell adhesion molecules, CLDN1, -5 and 
-11, cadherins and several major histocompatibility 
complex genes were present. ‘Complement and 
coagulation cascade’ pathway included highly 
upregulated genes in endometriomas, such as C3, C7 
and SERPINA5 (Table  3), and several integrin genes 
(ITGA4, ITGA7, ITGA10, ITGA11 and ITGB4) from 
‘ECM-receptor interaction’ pathway were differentially 
expressed in studied cells (Supplementary Table  2). In 
addition, various other pathways were highlighted by 
g:Profiler software where ‘Calcium signalling pathway’ 
and ‘PI3K-Akt signalling pathway’ had the highest 
number of DEGs involved (29 and 43 genes, respectively; 
Supplementary Table 2).
Validation of selected DEGs
Several genes from the complement cascade, cell 
adhesion pathways and SERPINE2 were selected 
according to sequencing data for further validation in 
stromal cells from eu- and ectopic endometrial tissues. 
Real-time PCR analyses confirmed differential expression 
of all studied genes (Fig.  2), showing upregulation in 
ectopic endometrial stroma.
Complement pathway genes in endometrial 
stromal cells are not regulated by PF from 
endometriosis patients
Next, in order to find out whether the higher expression 
of complement pathway genes in lesions could be 
caused by PF composition of endometriosis patients, 
primary eutopic endometrial stromal cells from nine 
women (three women without endometriosis and six 
women with the disease) were cultured and treated 
with cell culture medium containing 25% of PF 
collected from endometriosis patients. To avoid bias 
from individual differences in PF composition, pooled 
PF from six endometriosis patients with different stages 
of the disease was used. The relative expression of 
C3, CD55 and CFH was measured from cells before 
cultivation (uncultured), after achieving confluency but 
before treatment with PF (0 h), and 6, 12 and 24 h after 
adding PF. In parallel, untreated cells from the same 
biopsies were cultured and analysed at the same time 
points (Fig. 1A).
The uncultured stromal cells showed gene expression 
levels comparable to FACS-isolated stromal cells used 
for determining the mRNA differences between eu- 
and ectopic samples. The studied expression levels in 
endometrial stromal cells of endometriosis-free women 
and patients with the disease were similar and were 
grouped together for further analysis. No significant 
impact of PF on C3, CD55 and CFH levels in stromal 
cells were observed during the 24-h treatment time 
compared to untreated cells (Fig.  1B; all P > 0.05); 
Table 2 Primer sequences used in the study.
Gene name Strand Primer sequence 5′→3′
ESAM Forward CCTTTCGTCTTCCATGGCTG
 Reverse AGCAACCCCAGTCCAACC
A2M Forward AGTCTGGTTCTTCTCCTCTTGG
 Reverse CCCTGACAGACTCCAAGGAA
SERPINA5 Forward GAACCTCGATAGCAATGCGG
 Reverse AGTGATACTGATCCTCGCGG
SELP Forward GTCAGCTACTCCACCAACCT
 Reverse ACTGCTGTCCATTGTCCTGA
CLDN1 Forward GTGCGATATTTCTTCTTGCAGGTC
 Reverse TTCGTACCTGGCATTGACTGG
CLDN11 Forward GTACCACTGCAAGCCCCT
 Reverse TCAGCAGCAGTAAAATGGCC
SERPINE2 Forward AATGAAACCAGGGATATGATTGAC
 Reverse TTGCAAGATATGAGAAACATGGAG
C3 Forward GACTCCATCACCACGTGGGA
 Reverse CCTGCATTACTGTGACCTCGAA
CD55 Forward TCCTGGCGAGAAGGACTCAGTGA 
 Reverse AGCCTTGTTGGCACCTCGCA 
CFH Forward TTGCACACAAGATGGATGGT
 Reverse GGATGCATCTGGGAGTAGGA
SDHA Forward TGGGAACAAGAGGGCATCTG
 Reverse CCACCACTGCATCAAATTCATG
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however, considerable increase in C3 and CD55, and 
decrease in CFH levels were detected in cultured (0, 6, 
12 and 24 h) vs uncultured cells (Fig. 1B; all P < 0.05), 
indicating that cell culturing per se had larger effect on 
complement gene expression levels compared to the 
influence of PF.
Discussion
Endometriotic lesion biopsies typically contain 
only a small proportion of endometrial stromal and 
epithelial cells in addition to various other cell types 
and surrounding tissue that impedes the detection 
of gene expression alterations in endometriotic 
cells (Sanchez  et  al. 2015). In addition, molecular 
profiles correlate to the anatomical location of lesions 
(Meola  et  al. 2010, Ballester  et  al. 2012, Filippi  et  al. 
2016) and therefore specific cell populations from the 
selected type of lesions should be studied. For the first 
time to our knowledge, we used high-throughput mRNA 
sequencing to reveal transcriptome changes in uncultured 
endometrial stromal cells from endometriomas and 
paired samples of eutopic endometrium. Our analysis 
revealed over 1300 DEGs, and confirmed associations 
between endometriosis and numerous pathways, 
including cell adhesion along with complement and 
coagulation cascade.
It is widely accepted that the impairment of innate 
immune system via the complement system plays 
a crucial part in the pathogenesis of endometriosis. 
Higher expression of complement components, e.g. 
C3, C7, CFH and CFD, in endometriomas has been 
Table 3 Top 15 up- and downregulated genes between stromal cells from endometriomas and endometrium.
Gene Description Log2 fold change Adjusted P value (BaySeq)
Upregulated in endometriomas
C3 Complement component 3 7.9 6.4E-11
HP Haptoglobin 8.7 1.7E-05
SERPINA5 Serpin family A member 5 6.7 3.6E-05
FMO2 Flavin-containing monooxygenase 2 6.4 5.7E-05
TCF23 Transcription factor 23 5.9 7.8E-05
S100A10 S100 calcium-binding protein A10 6.2 1.3E-04
C7 Complement component 7 7.6 1.6E-04
NR5A1 Nuclear receptor subfamily 5 group A member 1 8.8 2.2E-04
BST2 Bone marrow stromal cell antigen 2 5.0 3.5E-04
GPX3 Glutathione peroxidase 3 6.4 3.9E-04
DAPK1 Death-associated protein kinase 1 4.4 4.4E-04
SLC19A3 Solute carrier family 19 member 3 6.5 4.8E-04
CLDN11 Claudin 11 6.5 6.3E-04
ARHGEF28 Rho guanine nucleotide exchange factor 28 3.9 6.9E-04
SCN7A Sodium voltage-gated channel alpha subunit 7 8.5 8.7E-04
Downregulated in endometriomas
KIAA1210 KIAA1210 −5.2 5.7E-06
C8orf31 Chromosome 8 open reading frame 31 −4.5 1.0E-04
SDK2 Sidekick cell adhesion molecule 2 −4.4 1.9E-04
DOK7 Docking protein 7 −5.4 2.6E-04
LRFN5 Leucine-rich repeat and fibronectin type III domain containing 5 −4.1 3.0E-04
TMEM120B Transmembrane protein 120B −2.6 5.3E-04
GUCY1A2 Guanylate cyclase 1, soluble, alpha 2 −2.7 7.5E-04
PPP2R2C Protein phosphatase 2 regulatory subunit Bgamma −5.8 8.1E-04
ADAMTS16 ADAM metallopeptidase with thrombospondin type 1 motif 16 −4.5 1.0E-03
RCOR2 REST corepressor 2 −3.2 1.2E-03
TMEM132B Transmembrane protein 132B −4.2 1.4E-03
HSD11B2 Hydroxysteroid 11-beta dehydrogenase 2 −5.1 1.8E-03
ARSJ Arylsulfatase family member J −3.2 2.0E-03
GDF7 Growth differentiation factor 7 −5.2 2.2E-03
DUSP15 Dual specificity phosphatase 15 −2.2 2.3E-03
Figure 2 Gene expression level differences between stromal cells 
from endometrium and endometriomas studied by RNA sequencing 
and quantitative real-time PCR. Fold change values are given relative 
to endometrial stroma. All studied gene expression differences were 
statistically significant (P < 0.05). The error bars denote s.e.m. 
(standard error of the mean).
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demonstrated (Kobayashi et al. 2012, Suryawanshi et al. 
2014, Ahn  et  al. 2016) and, in our study, C3 showed 
the most significantly altered levels between eu- and 
ectopic endometrial stromal cells (Table 3). Moreover, 
in our study, complement central components (C3, C7, 
C1QA and C1QB) as well as complement inhibitors 
(CD55, CFH, C4BPB, SERPING1 and CLU) were 
upregulated at the same time. Complement regulatory 
proteins (including CD55, CFH and C4BP) prevent the 
complement system from being activated when it is not 
needed (Ferreira et al. 2010, Toomey et al. 2014). Several 
tumour cells express complement regulatory proteins at 
very high levels to protect the tissue from complement-
dependent cytotoxicity (Morgan  et  al. 2002). For 
example, in endometrial tumours, the overexpression of 
complement regulatory proteins CD55 and protectin has 
been linked to high resistance to complement-mediated 
cell destruction (Bellone  et  al. 2012). Therefore, we 
can speculate that the imbalances in complement 
activation and inhibition in endometriotic cells result in 
inflammation and, on the other hand, protect the cells at 
extrauterine location.
It has been hypothesised that one of the factors 
affecting complement gene expression levels in 
endometrial cells outside the normal environment 
is PF (Tao et al. 1997). PF is in direct contact with all 
pelvic surfaces where endometriotic lesions are most 
often located and seems to play a pivotal role in the 
pathogenesis of endometriosis by influencing the 
anatomical distribution of lesions (Bricou et al. 2008). 
In addition, PF of endometriosis patients has an altered 
composition (Gilabert-Estelles et al. 2007, Berkes et al. 
2014, Liu et al. 2016) that can modify miRNA expression 
of endometrial stromal cells (Braza-Boils  et  al. 2015). 
Moreover, the PF of endometriosis patients contains 
increased levels of cytokines (Taketani  et  al. 1992, 
Khorram et al. 1993, Pizzo et al. 2002) that can cause 
gene expression changes in endometrial stromal cells, 
including complement cascade genes (Chalpe 2015). 
Although an upregulation of several complement 
components in endometriomas has been previously 
demonstrated (Eyster  et  al. 2007, Hever  et  al. 2007, 
Borghese et al. 2008, Suryawanshi et al. 2014, Ahn et al. 
2016), we were the first who examined the influence of 
endometriosis PF on the expression level of complement 
components in endometrial stromal cells. Nevertheless, 
no differences in C3, CD55 and CFH levels were 
detected in cultured endometrial stromal cells treated 
with PF from endometriosis patients compared to 
untreated cultured stromal cells from the same patients. 
Thus, some factors other than the altered composition of 
PF must be involved in the complement gene regulation 
in endometriosis. However, differences in complement 
cascade gene expression levels were observed between 
cultured and uncultured stromal cells indicating that cell 
culturing has a significant impact on gene expression, an 
issue previously demonstrated by Barragan et al. (2016).
We also observed a rise in cell adhesion molecule 
(CAM) pathway gene levels in ectopic endometrial 
stromal cells. Increased levels of CAMs, including 
claudins, selectins, integrins and cadherins have 
been linked to the development and persistence of 
endometriotic lesions in peritoneal environment (Witz 
2003). CAMs take part in intercellular adhesion and 
interaction with the extracellular matrix. Through this 
mechanism, CAMs facilitate the binding of endometrial 
cells to ectopic sites. Besides cell-to-cell interactions, 
CAMs mediate various immune and inflammatory 
processes (Malik & Lo 1996), an attribute very commonly 
described in endometriosis. Aside from previously 
described CAMs, our sequencing data revealed several 
novel cell adhesion pathway genes including ESAM, 
CD6, CDH3, MAG, LRRC4B, NFASC, NLGN1 and 
NRXN1 that have not been described in relation to 
endometriosis before (Supplementary Table 1). Thereby, 
our study results confirmed the relevance of CAMs in 
the pathogenesis of endometriosis and added several 
novel candidates to the list of endometriosis-associated 
CAM-genes.
Several pathways highlighted in our study have 
also been linked to tumorigenesis (focal adhesion, 
ECM–receptor interaction, cytokine–cytokine receptor 
interaction and PI3K-Akt signalling pathway). 
Endometriosis and ovarian cancer share numerous 
common features including high oestrogen and cytokine 
concentration, oxidative stress, etc. that may activate 
these pathways; however, the association between 
endometriosis and ovarian cancer is still unclear, and 
it is generally accepted that endometriosis does not 
increase cancer incidence (Dunselman et al. 2014).
On protein level, our previous study revealed that 
the protein with the highest difference (FC 19.2) 
between cultured ectopic and eutopic stromal cells 
was glia-derived nexin (encoded by SERPINE2 gene) 
(Kasvandik  et  al. 2016). In the current study, we also 
demonstrated an overexpression of SERPINE2 mRNA 
(FC 17.1) in uncultured ectopic stromal cells. In cancers, 
the main functions of SERPINE2 are enhancement of 
cellular invasiveness and extracellular matrix production 
(Buchholz et al. 2003). Therefore, our results collectively 
hint that SERPINE2 could play a pivotal role in the 
pathogenesis of endometriosis by altering stromal cell 
invasive capabilities.
Despite the small number of samples in our mRNA 
sequencing analysis, we detected substantial differences 
in gene expression levels between eu- and ectopic 
endometrial stroma. The number of false positive 
associations was diminished using three differential 
expression analysis packages, and DEGs were 
considered true if confirmed by at least two analysis 
methods. The verification of selected targets by real-
time PCR confirmed the results of mRNA sequencing. 
The validity of our results is further supported by 
several previous studies reporting similar findings 
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(Eyster  et al. 2007, Hever  et al. 2007, Borghese  et al. 
2008, Sohler  et  al. 2013, Suryawanshi  et  al. 2014, 
Ahn  et  al. 2016), suggesting that if a certain gene is 
highly upregulated in endometrial cells from ectopic 
location, the surrounding tissue does not hinder the 
detection of this gene. In addition, as we analysed the 
specific population of stromal cells from endometrioma 
and endometrium, we were able to identify several 
new genes previously not described in endometriosis 
studies. Therefore, studying specific cell populations has 
clear advantages over analysing whole tissue biopsies, 
as this approach enables to reveal changes that occur 
in certain endometrial cells. For example, an increased 
expression of genes associated with leukocytes (e.g. 
CD4, CD45R0, CD8A, CD3D and CD48) has been 
observed in endometriotic lesions (Ahn  et  al. 2016). 
In our study, we did not detect higher expression of 
these genes in stromal cells from lesions compared to 
eutopic endometrium, demonstrating that exploring 
specific cell populations enables to study changes that 
have occurred particularly in endometrial cells from 
ectopic locations.
In conclusion, this is the first study utilizing uncultured 
CD10+ stromal cells to discover large-scale alterations 
from eu- and ectopic endometria of endometriosis 
patients. Our data confirmed the upregulation of several 
cell adhesion molecules and complement components 
in endometriotic stromal cells and added new 
molecular candidates for further studies in pathogenesis 
of endometriosis. The benefits of the current study 
in identifying novel genes in endometriosis provide 
proof that in the future, all cell types of endometriotic 
lesions should be examined separately to uncover 
mechanisms for the disease development that have thus 
far remained hidden.
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